Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, octubre 01
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Elanco Animal Health Inc
ELAN
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$22.12
-0.27
-1.21%
Últ. Act.: Oct 1, 10:11 AM
$22.45
0.06
0.27%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Elanco Animal Health Financials
Elanco Animal Health (ELAN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenrelia growth and expanding margins.
Vandana Singh
PRO
Elanco Animal Health Sees Q3 Adj EPS $0.19-$0.22 vs $0.20 Est; Sees Sales $1.195B-$1.220B vs $1.192B Est
Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate. sees sales of $1.195 billion-$1.220 billion vs $1.192 billion analyst estimate.
Benzinga Newsdesk
PRO
Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 Est; Raises FY2026 Sales Guidance from $5.010B-$5.085B to $5.090B-$5.140B vs $5.062B Est
Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 analyst estimate. Raises FY2026 sales outlook from $5.010 billion-$5.085 billion to $5.090 billion-$5.140 billion
Benzinga Newsdesk
PRO
Elanco Animal Health Q2 Adj. EPS $0.34 Beats $0.27 Estimate, Sales $1.368B Beat $1.313B Estimate
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum
Elanco Animal Health rallies after emergency use approvals and Q1 earnings beat, with higher guidance.
Vandana Singh
